Loncar Cancer Immunotherapy ETF (NYSEARCA:CNCR) Stock Price Down 0.9%

Shares of Loncar Cancer Immunotherapy ETF (NYSEARCA:CNCRGet Rating) traded down 0.9% during mid-day trading on Friday . The stock traded as low as $16.10 and last traded at $16.10. 1,559 shares traded hands during trading, a decline of 78% from the average session volume of 7,115 shares. The stock had previously closed at $16.24.

Loncar Cancer Immunotherapy ETF Trading Down 0.9 %

The business has a fifty day moving average price of $16.43 and a 200-day moving average price of $16.21.

Featured Stories

Receive News & Ratings for Loncar Cancer Immunotherapy ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Loncar Cancer Immunotherapy ETF and related companies with MarketBeat.com's FREE daily email newsletter.